John H. Parrish
Founder at BioVascular, Inc.
Network origin in John H. Parrish first degree
Entity | Entity type | Industry | |
---|---|---|---|
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA.
7
| Private Company | Pharmaceuticals: Major | 7 |
Valley Forge Pharmaceuticals, Inc.
Valley Forge Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valley Forge Pharmaceuticals, Inc. develops ophthalmic pharmaceuticals. It is an early stage ophthalmic pharmaceutical company focused on preventing the development of myopia in children and utilizing proprietary pharmaceutical drugs to control abnormal ocular development. The company is headquartered in Irvine, CA.
1
| Private Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John H. Parrish via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
ALIGN TECHNOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
ReVision Optics, Inc.
ReVision Optics, Inc. Electronic ComponentsElectronic Technology ReVision Optics, Inc. develops optical solutions for the treatment of presbyopia. The company also develops Raindrop Near Vision Corneal Inlay, which is a refractive surgery solution. ReVision Optics was founded by Hansen A. Yuan, Adrian Koppes and Alok Nigam in 1996 and is headquartered Lake Forest, CA. | Electronic Components | Director/Board Member | |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
Stanford University | College/University | Graduate Degree | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Biotechnology | Corporate Officer/Principal | |
Rice University | College/University | Doctorate Degree | |
Emory University | College/University | Corporate Officer/Principal | |
YPSOMED HOLDING AG | Medical Specialties | Director/Board Member | |
Oregon State University | College/University | Undergraduate Degree | |
University of California, Irvine | College/University | Doctorate Degree | |
University of California San Diego | College/University | Undergraduate Degree | |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member | |
University of Giessen | College/University | Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Investment Managers | Corporate Officer/Principal | |
Biotech Ventures GP Ltd.
Biotech Ventures GP Ltd. Financial ConglomeratesFinance Part of Bellevue Group AG, Biotech Ventures GP Ltd. is a venture capital fund. The company is based in St. Peter Port, UK. | Financial Conglomerates | Corporate Officer/Principal | |
MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
Beecham Pharmaceuticals | Corporate Officer/Principal | ||
binx health, inc.
binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Information Technology Services | Director/Board Member | |
Glaxo, Inc. | Corporate Officer/Principal | ||
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
ZoomIn Online (India) Pvt Ltd.
ZoomIn Online (India) Pvt Ltd. Internet Software/ServicesTechnology Services ZoomIn Online (India) Pvt Ltd. provides an online photo service that enables customers to store, share and print their digital photos. It allows customers around the world to upload unlimited photos and share them with friends and family. The firm also operates an online store for camera and camera accessories, including photobooks, canvases, photo prints, posters, calendars, mugs, magnets and frames. The company was founded in 2007 and is headquartered in Mumbai, India. | Internet Software/Services | Director/Board Member | |
Convergent Dental, Inc.
Convergent Dental, Inc. Medical SpecialtiesHealth Technology Convergent Dental, Inc. develops and manufactures dental devices. The firm develops Solea, a computer-aided, CO2 laser system for both hard and soft tissue indications. The company was founded by Nathan P. Monty in 2011 and is headquartered in Needham, MA. | Medical Specialties | Director/Board Member | |
NanoSmart Pharmaceuticals, Inc.
NanoSmart Pharmaceuticals, Inc. BiotechnologyHealth Technology NanoSmart Pharmaceuticals, Inc. is a privately-held corporation based in Laguna Hills, CA. The private company is developing nanoparticle drug delivery platforms, including utilization of anti-nuclear antibody (ANA) to enable targeted drug delivery of existing drug therapies to areas of necrosis present in virtually all solid cancer tumors. Henry J. Smith has been the CEO of the company since 2006. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BB Biotech Ventures | Chief Executive Officer | ||
ARDVRK Technologies LLC
ARDVRK Technologies LLC Information Technology ServicesTechnology Services ARDVRK Technologies LLC develops software solutions. It focuses on augmented and virtual reality applications for healthcare, life sciences, and medical device companies. The company was founded by John O’Brien, Paul Jahn, and Michael O’Brien and is headquartered in Austin, TX. | Information Technology Services | Director/Board Member | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
Binx Health Ltd.
Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
Retinal Degeneration Fund | Director/Board Member | ||
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Ariceum Therapeutics GmbH
Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Gund Arena Co. | Director/Board Member | ||
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
United States | 31 |
Switzerland | 12 |
Germany | 3 |
United Kingdom | 3 |
India | 3 |
Sectoral
Health Technology | 20 |
Consumer Services | 11 |
Finance | 7 |
Technology Services | 4 |
Commercial Services | 4 |
Operational
Director/Board Member | 56 |
Corporate Officer/Principal | 20 |
Chairman | 8 |
Independent Dir/Board Member | 7 |
Undergraduate Degree | 6 |
Most connected contacts
- Stock Market
- Insiders
- John H. Parrish
- Company connections